Esparcia, Rosilyn L.
HRN: 22-83-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
AMPICILLIN 1GM (VIAL)
10/28/2023
10/29/2023
IV
2 Grams
Loading Dose
Leaking BOW
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes